ArticleDiabetologia2026

SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.

Lynne Chepulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.